ClinicalTrials.gg
CompletedNCT07770880Updated Aug 18, 2026

Impact of Repeated Virtual Reality Training on Markers of Stress

An interventional study of Active Shooter and Target Practice in Stress, Acute Stress Reaction and Virtual Reality, sponsored by Texas State University. Completed at 1 site in United States. Open to participants aged 18 Years to 39 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-18.

Sponsored by Texas State University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Oct 2025, registered Aug 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 39 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 26 studies in Stress Disorders, Traumatic, Acute with a site in United States — 9 open to participants now, 9 under way, none of them phase 3. Stress Disorders, Traumatic, Acute · United States.

Enrollment
18th of 24
50 · median 73
Started
2025
with 4 others
No phase
14 of 26
6 open now
Registered
26th of 26
by date
Lead sponsor
2 of 26
Texas State University

Among the 26 studies in Stress Disorders, Traumatic, Acute with a site in United States, this one is the 18th largest by enrollment of the 24 interventional ones that give a count, is one of 5 that started in 2025, is one of 14 with no phase, and was the 26th registered.

Stress Disorders, Traumatic, Acute

58 studies on the registry are indexed under Stress Disorders, Traumatic, Acute; 15 are open to participants now.

Browse Stress Disorders, Traumatic, Acute studies →

Open to participants now

9 of the 26 studies in Stress Disorders, Traumatic, Acute with a site in United States are open now. Recruiting first, the newest first:

4 more — sign in →

All 9 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 9 Stress Disorders, Traumatic, Acute studies recruiting now, 2 set no upper age limit and 7 stop at 75 or younger; 1 takes children under 18; 3 take healthy volunteers.

This study: 18 Years to 39 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 26 studies in Stress Disorders, Traumatic, Acute with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to examine whether repeated exposure to an active shooter or target practice virtual reality (VR) scenario alters physiological and psychological stress responses over time. Specifically, this study will determine whether the pattern and magnitude of stress habituation differ between the two VR conditions.

Read the detailed description

This study examines the effects of repeated virtual reality (VR) exposure on physiological and psychological stress responses by comparing an active shooter scenario with a target practice scenario. Repeated exposure to a stressor may result in changes in physiological and psychological responses over time, a process known as stress habituation. Therefore, the goal of this study is to determine whether repeated exposure to these two VR scenarios results in different patterns of stress habituation. Heart rate, salivary stress biomarkers, and self-reported anxiety will be assessed across repeated VR exposures to evaluate changes in stress responses over time. The findings from this research may provide insight into how stress responses change with repeated exposure to different types of VR scenarios and may inform the development of training approaches for individuals in high-stress occupations.

03

Conditions studied

  • Stress
  • Acute Stress Reaction
  • Virtual Reality
  • Active Shooter
  • Law Enforcement Training

Keywords

  • Stress
  • Stress biomarkers
  • Salivary Alpha-Amylase (sAA)
  • Salivary Secretory Immunoglobulin A (SIgA)
  • Acute stress
  • State Anxiety Inventory (SAI) scale
  • Active shooter
  • Virtual Reality (VR) training
  • Law enforcement training
  • Target practice
04

Who can participate

Ages eligible
18 Years to 39 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Generally healthy
  • Between the ages of 18-39
  • Student at texas state

Exclusion criteria

Exclusion Criteria:

  • No known cardiovascular or metabolic diseases
  • Free from a major stressor in the last 30 days (recent divorce, birth of child, miscarriage, etc.)
  • Not currently taking medication that can impact results (e.g., psychiatric medication typically prescribed for psychological disorders such as depression, anxiety, etc.)
  • Must also be free from any known psychiatric or physical illness (e.g., diabetes, myocardial infarction, stroke, Alzheimer's disease, alcoholism, epilepsy, severe motion sickness, etc.).
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Active Shooter

    Group assigned to active shooter scenarios only

    Other: Active Shooter

  • Experimental
    Target Practice

    Group assigned to two target practice scenarios and one active shooter scenario for the third trial only.

    Other: Target Practice

Interventions

  • OtherActive Shooter

    Participants experienced a virtual reality simulation lasting \~3 minutes. Participants took on the roll of a law enforcement officer responding to an active shooter situation in a gas station (trial 1), home (trial 2), and school (trial 3).

  • OtherTarget Practice

    Participants experienced a virtual reality simulation lasting \~3 minutes. Participants had two trials of target practice training and one trial of an active shooter scenario where they responded as a law enforcement officer in a school.

06

What researchers measure

Primary outcomes

  1. State Anxiety Inventory (SAI)

    The SAI is a 6 question survey on a 24 point scale, asking the subject to record how they feel. Questions asked were "I am calm," I am tense," "I am worried," "I am relaxed," etc. Subjects were asked to fill this out 4 times throughout the study, alongside HR and saliva samples.

    Time frame: Timepoint 1-4 were 20 minutes pre, immediately pre, immediately post, and 15 minutes post

  2. Heart Rate

    Heart rate was recorded immediately prior to each saliva sample using a Polar Verity Sense heart rate wrist/arm strap.

    Time frame: HR was recorded 4 times, before each saliva sample period

  3. Secretory Immunoglobulin-A

    SIgA is a marker of immune function and salivary SIgA concentrations tend to increase when exposed to stress

    Time frame: Measured using the saliva samples taken at timepoints 1-4 (20 min pre, immediately pre, immediately post, 15 min post)

  4. Salivary Alpha Amylase

    sAA is an enzyme involved in digestive processes. Amylase concentrations in saliva have been shown to reflect sympathetic stress. Thus, as sympathetic stress increases, salivary amylase concentrations tend to increase.

    Time frame: Measured using the saliva samples taken at timepoints 1-4 (20 min pre, immediately pre, immediately post, 15 min post)

07

Study locations

1 site
  • Texas State University
    San Marcos, Texas 78666, United States
08

References and documents

Individual participant data

Plan to share: No — IRB at Texas State does not allow the sharing of individual data, and all data has already been made unidentifiable for this study.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2025 to primary completion in May 2026, 7 months.

Of 25 interventional studies with no phase under Stress Disorders, Traumatic, Acute, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 35. This study's 7 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 13, 2026
First posted
Aug 18, 2026
StartActual
Oct 1, 2025
Primary completionActual
May 1, 2026
CompletionActual
May 1, 2026
Last update
Aug 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07770880
Lead sponsor
Texas State University
Responsible party
Matt McAllister (Associate Professor, Texas State University) — Principal investigator
First posted
Aug 18, 2026
Start date
Oct 1, 2025
Primary completion
May 1, 2026
Completion
May 1, 2026
Last update
Aug 18, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion